Figure 1
Rituximab blocks CD20 binding, but not CD45. (A) Rituximab blocks CD20 binding by tositumomab to Ramos cells, (B) but has no impact on CD45 binding by BC8.
Rituximab blocks CD20 binding, but not CD45. (A) Rituximab blocks CD20 binding by tositumomab to Ramos cells, (B) but has no impact on CD45 binding by BC8.
